An internationally renowned expert in the field of gastroenterology and inventor of therapeutic candidates, RHB-104 for Crohn's disease and RHB-105 for the treatment of H. pylori
RedHill Biopharma will presnet its recent clinical developments and business updates.
Registration is required, the number of participants is limited.
In order to register for please contact Merav Shiryan, no later than Oct. 15th.